Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS)
<p dir="ltr">The COVID-19 pandemic has affected the global socioeconomic and healthcare infrastructure. Vaccines have been the cornerstone in limiting the global spread of the pandemic. However, the mass scale vaccination has resulted in some unanticipated adverse events. Arguably th...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , |
| منشور في: |
2022
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513535851102208 |
|---|---|
| author | Zohaib Yousaf (9617058) |
| author2 | Fateen Ata (12217764) Riyadh Ali Mohammed Hammamy (17563143) |
| author2_role | author author |
| author_facet | Zohaib Yousaf (9617058) Fateen Ata (12217764) Riyadh Ali Mohammed Hammamy (17563143) |
| author_role | author |
| dc.creator.none.fl_str_mv | Zohaib Yousaf (9617058) Fateen Ata (12217764) Riyadh Ali Mohammed Hammamy (17563143) |
| dc.date.none.fl_str_mv | 2022-05-01T00:00:00Z |
| dc.identifier.none.fl_str_mv | 10.1016/j.tru.2022.100104 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/Thrombosis_post-mRNA-based_SARS-CoV-2_vaccination_BNT162b2_Time_to_think_beyond_thrombosis_with_thrombocytopenia_syndrome_TTS_/24745680 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Cardiovascular medicine and haematology Pharmacology and pharmaceutical sciences VTE Thrombosis Thromboembolism COVID-19 vaccine SARS-CoV-2 BNT162b2 Pfizer mRNA-1273 Moderna AZD1222 Oxford–AstraZeneca |
| dc.title.none.fl_str_mv | Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS) |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <p dir="ltr">The COVID-19 pandemic has affected the global socioeconomic and healthcare infrastructure. Vaccines have been the cornerstone in limiting the global spread of the pandemic. However, the mass scale vaccination has resulted in some unanticipated adverse events. Arguably the most serious of these has been the development of widespread thrombosis with viral-vectored vaccines. We present a case of extensive thrombosis associated with the messenger RNA (m-RNA) vaccine.</p><h2>Other Information</h2><p dir="ltr">Published in: Thrombosis Update<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.tru.2022.100104" target="_blank">https://dx.doi.org/10.1016/j.tru.2022.100104</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_5fe0fe7eaf7baf0cf306aa0a0e5ee7cb |
| identifier_str_mv | 10.1016/j.tru.2022.100104 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/24745680 |
| publishDate | 2022 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS)Zohaib Yousaf (9617058)Fateen Ata (12217764)Riyadh Ali Mohammed Hammamy (17563143)Biomedical and clinical sciencesCardiovascular medicine and haematologyPharmacology and pharmaceutical sciencesVTEThrombosisThromboembolismCOVID-19 vaccineSARS-CoV-2BNT162b2PfizermRNA-1273ModernaAZD1222Oxford–AstraZeneca<p dir="ltr">The COVID-19 pandemic has affected the global socioeconomic and healthcare infrastructure. Vaccines have been the cornerstone in limiting the global spread of the pandemic. However, the mass scale vaccination has resulted in some unanticipated adverse events. Arguably the most serious of these has been the development of widespread thrombosis with viral-vectored vaccines. We present a case of extensive thrombosis associated with the messenger RNA (m-RNA) vaccine.</p><h2>Other Information</h2><p dir="ltr">Published in: Thrombosis Update<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.tru.2022.100104" target="_blank">https://dx.doi.org/10.1016/j.tru.2022.100104</a></p>2022-05-01T00:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1016/j.tru.2022.100104https://figshare.com/articles/journal_contribution/Thrombosis_post-mRNA-based_SARS-CoV-2_vaccination_BNT162b2_Time_to_think_beyond_thrombosis_with_thrombocytopenia_syndrome_TTS_/24745680CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/247456802022-05-01T00:00:00Z |
| spellingShingle | Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS) Zohaib Yousaf (9617058) Biomedical and clinical sciences Cardiovascular medicine and haematology Pharmacology and pharmaceutical sciences VTE Thrombosis Thromboembolism COVID-19 vaccine SARS-CoV-2 BNT162b2 Pfizer mRNA-1273 Moderna AZD1222 Oxford–AstraZeneca |
| status_str | publishedVersion |
| title | Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS) |
| title_full | Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS) |
| title_fullStr | Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS) |
| title_full_unstemmed | Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS) |
| title_short | Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS) |
| title_sort | Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS) |
| topic | Biomedical and clinical sciences Cardiovascular medicine and haematology Pharmacology and pharmaceutical sciences VTE Thrombosis Thromboembolism COVID-19 vaccine SARS-CoV-2 BNT162b2 Pfizer mRNA-1273 Moderna AZD1222 Oxford–AstraZeneca |